Latest Articles
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma - Barchart.com
Endometriosis Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Ferring Pharma, AbbVie, Myovant, Pfizer, AbbVie, Neurocrine Biosciences, ObsEva, Kissei Pharma Barchart.com
Published: Oct. 20, 2025, 2:34 p.m.
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider
Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider
Published: Oct. 20, 2025, 2:27 p.m.
Mara Wilson Returns To Her Middle School To Teach About Endometriosis - Endometriosis Foundation of America
Mara Wilson Returns To Her Middle School To Teach About Endometriosis Endometriosis Foundation of America
Published: Oct. 20, 2025, 2:25 p.m.
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability - Yahoo
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability Yahoo
Published: Oct. 20, 2025, 2:07 p.m.
Married to Med's 'Sweet Tea' on Why She's Pausing Baby Plans - Reality Blurb
Married to Med's 'Sweet Tea' on Why She's Pausing Baby Plans Reality Blurb
Published: Oct. 20, 2025, 2:05 p.m.
Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 - citybiz
Faeth Therapeutics’ $92 Million Total Funding Powers PIKTOR Phase 2 citybiz
Published: Oct. 20, 2025, 1:40 p.m.
Bathgate MP urges action on debilitating condition which affects one in 10 women - Daily Record
Bathgate MP urges action on debilitating condition which affects one in 10 women Daily Record
Published: Oct. 20, 2025, 1:34 p.m.
Cyclana Bio raises £5m for endometriosis drug discovery - UKTN
Cyclana Bio raises £5m for endometriosis drug discovery UKTN
Published: Oct. 20, 2025, 1:13 p.m.
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability - Clinical Trials Arena
ESMO 2025: MSD and Eisai’s endometrial cancer combo shows five-year durability Clinical Trials Arena
Published: Oct. 20, 2025, 1:12 p.m.
From waterways to wombs: Widespread threats of plastic pollution - WUNC
From waterways to wombs: Widespread threats of plastic pollution WUNC
Published: Oct. 20, 2025, 1:11 p.m.
Link copied to clipboard!